整形外科用ギプス・スプリントの世界市場-2022-2029

市場概要

世界の整形外科用ギプス・スプリント市場は、予測期間（2022-2029年）においてCAGR6.1％で成長すると予測されています。

整形外科用ギプス・スプリントは、負傷した骨や関節を支え、固定するために使用される器具です。一般的には、骨折やけがが治るまでの間、骨や関節を保護するために使用されます。ギプスは、石膏やグラスファイバーなどの丈夫な素材でできており、怪我をした部分の皮膚に直接貼り付けます。一方、スプリントは通常、発泡スチロールやパッド付きアルミニウムなどの柔らかい素材でできており、ストラップで手足に固定されます。スプリントは、ギプスほど固定を必要としない怪我によく使用されます。ギプス・スプリントは、負傷した手足を安定させ、適切な治癒を可能にするために設計されています。

市場力学

整形外科用ギプス・スプリントの世界市場の成長は、技術の進歩、骨折、捻挫、脱臼などの損傷の種類と重症度、子供と大人への適合、予想される治療時間の提供、ギプス・スプリントに対する患者の嗜好の増加によってもたらされます。

整形外科用ギプス・スプリントの技術進歩が市場成長を牽引

技術の進歩は、世界の市場を牽引しています。2020年にBiomed Research Internationalに掲載された記事によると、整形外科分野における3Dプリント技術は、機能のパーソナライズと迅速な製造における利点から、急速に成長しています。圧力をより適切に分散させるために、3Dプリントされたギプスは、治療中により快適になると予測されています。パーソナライズされたデザイン、3Dプリントのための軽量素材の使用という利点に加え、この新しいギプスは、よりファッショナブルで携帯性に優れています。

さらに、材料メーカーのダシエットは、病院やヘルスケアセンターをターゲットにした製品ライン「UCAST」を発売し、患者と介護スタッフの両方にとって骨折治療をより迅速かつ安全に行えるようにしています。一般的なギプスの作成には30分ほどかかりますが、熱可塑性プラスチック製の「UCAST」は5分程度で装着できます。UCASTスプリントは、毒性もアレルギー性もない材料で作られているため、医療チームが保護具を着用する必要はありません。スプリントは患者にとって快適で、軽量で、通気性があります。

整形外科用ギプス・スプリントの入手が困難なことが市場成長の妨げとなる

しかし、整形外科用ギプス・スプリントを提供できる医療施設やヘルスケアプロバイダの数は限られています。そのため、こうした地域に住む個人がこの治療を受けることは困難です。さらに、整形外科用ギプス・スプリントの費用や保険適用範囲も、地域によっては治療へのアクセスを制限する場合があります。

COVID-19の影響分析

COVID-19の大流行は、整形外科用ギプス・スプリント市場に大きな影響を与えています。COVID-19の蔓延を防ぐため、新しいプロトコルでは、医師と患者の接触を減らし、接触時間を短くし、安全な距離を保つことが推奨されています。また、安定した足首の骨折や後肢／中足／前肢の損傷など、別の方法を適用する場合は、不必要なギプス包帯を避けることが推奨されています。

2020年にThe Archives of Bone and Joint Surgeryに掲載された論文のように、キャスティング時の接触時間を短縮するために、カスタムメイドの3Dプリントされたギプス/スプリントを遠隔で注文することができ、患者による自己抜去を可能にしながら、通院回数を減らし接触時間を短縮させることが可能です。ギプスは、市販の3Dスキャナーで手足を5～10秒で3Dスキャンした後にプリントされます。従来のギプスとは異なり、3Dプリントされたギプス／スプリントは洗浄可能で、COVID-19のような感染症の危機の際にも有利です。

目次

第1章 市場調査手法とスコープ

• 調査手法
• 調査目的および調査範囲

第2章 市場の定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

• 市場影響要因
  • 促進要因
    • 交通事故件数の増加
    • 筋骨格系損傷とスポーツ傷害の増加
  • 抑制要因
    • 抑制要因：ギプス・スプリントの常用は、関節の硬直や慢性疼痛を引き起こします。
  • ビジネスチャンス
  • 影響分析

第5章 産業分析

• ポーターのファイブフォース分析
• サプライチェーン分析
• 規制分析

第6章 COVID-19の分析

• COVID-19の市場分析
  • COVID-19以前の市場シナリオ
  • COVID-19の現在の市場シナリオ
  • COVID-19の後、または将来のシナリオ
• COVID-19の中での価格ダイナミクス
• 需要-供給スペクトラム
• パンデミック時の市場に関連する政府の取り組み
• メーカーの戦略的取り組み
• まとめ

第7章 製品タイプ別

• ギプス
• スプリント

第8章 傷害の種類別

• 手
• 指
• 手首
• ひじ
• 膝
• 足首
• 足
• その他

第9章 用途別

• 急性期骨折
• 捻挫
• 初期安定化

第10章 材料別

• ガラス繊維
• 石膏

第11章 エンドユーザー別

• 病院
• 整形外科クリニック
• その他

第12章 地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他欧州
• 南米
  • ブラジル
  • アルゼンチン
  • その他の南米地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • オーストラリア
  • その他アジア太平洋地域
• 中東・アフリカ地域

第13章 競合情勢

• 主な展開と戦略
• 企業シェア分析
• タイプ別ベンチマーク

第14章 企業プロファイル

• 3M
  • 企業概要
  • 製品ポートフォリオと説明
  • 主なハイライト
  • 財務概要
• BSN medical GmbH
• DeRoyal Industries, Inc.
• DJO, LLC
• Orfit Industries n.v.
• Ossur hf.
• Prime Medical, Inc.
• Spencer Italia S.r.l.
• Stryker Corporation
• Zimmer Holdings, Inc.

第15章 整形外科用ギプス・スプリントの世界市場-DataM

Market Overview

The Global "Orthopedic Casts and Splints Market" is expected to grow at a CAGR of 6.1% during the forecasting period (2022-2029).

Orthopedic casts and splints are devices used to support and immobilize injured bones and joints. They are commonly used to protect bones and joints while they heal after a fracture or injury. Casts are made of sturdy material, such as plaster or fiberglass, and are applied directly to the skin over the injury. On the other hand, splints are usually made of a softer material, such as foam or padded aluminum, and are secured to the limb with straps. Splints are often used for injuries that do not require as much immobilization as a cast. Casts and splints are designed to stabilize the injured limb and allow for proper healing.

Market Dynamics

The global orthopedic casts and splints market growth is driven by technological advancements; the type and severity of the injury, such as fractures, sprains, and dislocations, suitable for children and adults, provide expected treatment time, and increasing patient preference for casts and splints.

Technology advancements in orthopedics casts and splints drives the market growth

The increasing advancements in technology drive the market worldwide. According to article published in Biomed Research International in 2020, 3D printing technology in the orthopedic field is growing swiftly because of its advantages in personalizing features and rapid manufacture. For the pressure to be more appropriately distributed, a 3D-printed cast is predicted to be more comfortable during the treatment. In addition to the benefit of personalized design and the use of lightweight materials for 3D printing, the novel cast is also more fashionable and portable.

In addition, Materials company Dassiet has launched UCAST, a product line targeted towards hospitals and healthcare centers, making fracture treatment faster and safer both for the patient and nursing staff. A typical cast can take up to 30 minutes to make, while the thermoplastic UCAST cast can be applied in around five minutes. The medical team does not need to wear protective gear when casting UCAST splints because they are constructed entirely of neither toxic nor allergic materials. The splint is comfortable for the patient, lightweight, and breathable.

Limited availability of orthopedic casts and splints will hamper the growth of the market

However, a limited number of medical facilities or healthcare providers can provide orthopedic casts and splints. This can make it difficult for individuals in these areas to access this treatment. In addition, the cost and insurance coverage of orthopedic casts and splints may also limit access to treatment in some areas.

COVID-19 Impact Analysis

The COVID-19 pandemic has considerably affected the orthopedics casts and splints market. To lesson the chance of the spread of COVID-19, the emerging protocols advise less physician-patient contact, shortening the contact time, and keeping a safe distance. It is recommended that unnecessary casting be avoided if alternative methods are applied, such as in stable ankle fractures and hindfoot/midfoot/forefoot injuries.

As per the article published in The Archives of Bone and Joint Surgery in 2020, to reduce the contact time during casting, custom-made 3D printed casts/splints can be ordered remotely, which reduces the number of visits and shortening the contact time while it allows for self-removal by the patient. The cast is printed after the limb is 3D scanned in 5-10 seconds using commercially available 3D scanners. In contrast to conventional casting, a 3D-printed cast/splint is washable and advantageous during an infectious crisis such as the COVID-19 pandemic.

Segment Analysis

The splints segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

The splints segment accounts for the highest market share. Splint materials are distinguished from casts. Other names, including soft cast or temporary cast, frequently refer to splints. Splints are frequently utilized in the early stages of a fracture or when more firm immobilization is not required. For instance, patients rarely leave the emergency room of a hospital with a cast. Instead, patients are often splinted once their fracture has been identified. Splints are created from a variety of materials. Because there is more space for swelling in this situation, the splint has an advantage. Compartment syndrome is cast therapy's potentially fatal side effect after a fracture. This syndrome develops when the body experiences an excessive pressure buildup, and it can happen after a fracture when swelling takes place in an area constrained by a cast. While compartment syndrome typically causes severe pain, this can be difficult to distinguish from normal fracture pain after a broken bone. Therefore, most healthcare providers don't want to risk a complication and will use a splint to ensure adequate room for swelling.

Geographical Analysis

North America region holds the largest market share of the global Orthopedic Casts and Splints market

North America dominates the market for Orthopedic Casts and Splints and is expected to show a similar trend over the forecast period. It is common for orthopedic casts and splints to treat fractures and other injuries to bones and joints. These devices immobilize and support affected body parts while they heal. In North America, orthopedic casts and splints are likely to vary depending on the specific population being treated and the availability of alternative treatments.

There has been a surge toward in recent years using more advanced and specialized orthopedic devices, such as custom-made splints and braces, as well as rehabilitation and physical therapy to help patients recover from injuries and surgeries. There has also been an increase in less invasive procedures, such as arthroscopy, which can often be performed using splints rather than casts.

In addition, in February 2022, Rural Utah Company Merit3D Brought 3D Printed Cast Capabilities to the Western United States. Improvement in scanning technology for tablets and phones has allowed doctors and nurses to carry the scanning equipment in their pockets, and within a day or two, patients are wearing a lightweight, breathable cast that fits the contours of their own arm.

Competitive Landscape

The orthopedic casts and splints market is a moderately competitive presence of local and global companies. Some of the key players which are contributing to the growth of the market are 3M, BSN medical GmbH, DeRoyal Industries, Inc., DJO, LLC, Orfit Industries n.v., Ossur hf., Prime Medical, Inc., Spencer Italia S.r.l., Stryker Corporation, and Zimmer Holdings, Inc., among others. The major players are adopting several growth strategies, such as product launches, acquisitions, and collaborations, contributing to the growth of the orthopedic casts and splints market globally.

For instance,

• In July 2022, Hanger, Inc. agreed to be acquired by Patient Square Capital, a dedicated healthcare investment firm.

3M

Overview:

3M is a multinational company founded in 1902 and headquartered in the United States. It operates in the industry, worker safety, United States health care, and consumer goods.

Product Portfolio:

3M Scotchcast Conformable Splint: This product offers low-profile, one-sided, felt less bulky padding, so it molds more easily to the patient for a closer, more conformable fit. An All-in-one splint allows for easy application and time savings. The faster application increases patient turnaround. It provides strong, lightweight support in minutes to encourage early patient mobility. It is less messy than plaster splints for easy application and faster cleanup.

The global Orthopedic Casts and Splints market report would provide access to approximately 75+ market data tables, 75+ figures, and in the range of 200 (approximate) pages.

Table of Contents

1. Market Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

• 4.1. Market Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Increasing number of road accidents
    • 4.1.1.2. Increasing number of musculoskeletal injuries and sports Injuries
  • 4.1.2. Restraints:
    • 4.1.2.1. Constant Usage of a Casts or Splints Many a Time Leads to Joint Stiffness, Chronic Pain
  • 4.1.3. Opportunity
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Forces Analysis
• 5.2. Supply Chain Analysis
• 5.3. Regulatory Analysis

6. COVID-19 Analysis

• 6.1. Analysis of Covid-19 on the Market
  • 6.1.1. Before COVID-19 Market Scenario
  • 6.1.2. Present COVID-19 Market Scenario
  • 6.1.3. After COVID-19 or Future Scenario
• 6.2. Pricing Dynamics Amid Covid-19
• 6.3. Demand-Supply Spectrum
• 6.4. Government Initiatives Related to the Market During the Pandemic
• 6.5. Manufacturer's Strategic Initiatives
• 6.6. Conclusion

7. By Product Type

• 7.1. Introduction
  • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
  • 7.1.2. Market Attractiveness Index, By Product Type
• 7.2. Casts*
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
• 7.3. Splints

8. By Injury Type

• 8.1. Introduction
  • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Injury Type
  • 8.1.2. Market Attractiveness Index, By Injury Type
• 8.2. Hand*
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
• 8.3. Finger
• 8.4. Wrist
• 8.5. Elbow
• 8.6. Knee
• 8.7. Ankle
• 8.8. Foot
• 8.9. Others

9. By Application

• 9.1. Introduction
  • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 9.1.2. Market Attractiveness Index, By Application
• 9.2. Acute Fractures*
  • 9.2.1. Introduction
  • 9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
• 9.3. Sprains
• 9.4. Initial Stabilization

10. By Material

• 10.1. Introduction
  • 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
  • 10.1.2. Market Attractiveness Index, By Material
• 10.2. Fiber Glass*
  • 10.2.1. Introduction
  • 10.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
• 10.3. Plaster

11. By End User

• 11.1. Introduction
  • 11.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
  • 11.1.2. Market Attractiveness Index, By End User
• 11.2. Hospitals*
  • 11.2.1. Introduction
  • 11.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
• 11.3. Orthopedic Clinics
• 11.4. Others

12. By Region

• 12.1. Introduction
  • 12.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
  • 12.1.2. Market Attractiveness Index, By Region
• 12.2. North America
  • 12.2.1. Introduction
  • 12.2.2. Key Region-Specific Dynamics
  • 12.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
  • 12.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Injury Type
  • 12.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 12.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
  • 12.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
  • 12.2.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 12.2.8.1. U.S.
    • 12.2.8.2. Canada
    • 12.2.8.3. Mexico
• 12.3. Europe
  • 12.3.1. Introduction
  • 12.3.2. Key Region-Specific Dynamics
  • 12.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
  • 12.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Injury Type
  • 12.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 12.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
  • 12.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
  • 12.3.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 12.3.8.1. Germany
    • 12.3.8.2. U.K.
    • 12.3.8.3. France
    • 12.3.8.4. Italy
    • 12.3.8.5. Spain
    • 12.3.8.6. Rest of Europe
• 12.4. South America
  • 12.4.1. Introduction
  • 12.4.2. Key Region-Specific Dynamics
  • 12.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
  • 12.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Injury Type
  • 12.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 12.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
  • 12.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
  • 12.4.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 12.4.8.1. Brazil
    • 12.4.8.2. Argentina
    • 12.4.8.3. Rest of South America
• 12.5. Asia Pacific
  • 12.5.1. Introduction
  • 12.5.2. Key Region-Specific Dynamics
  • 12.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
  • 12.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Injury Type
  • 12.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 12.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
  • 12.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
  • 12.5.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 12.5.8.1. China
    • 12.5.8.2. India
    • 12.5.8.3. Japan
    • 12.5.8.4. Australia
    • 12.5.8.5. Rest of Asia Pacific
• 12.6. Middle East and Africa
  • 12.6.1. Introduction
  • 12.6.2. Key Region-Specific Dynamics
  • 12.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
  • 12.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Injury Type
  • 12.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 12.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
  • 12.6.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

13. Competitive Landscape

• 13.1. Key Developments and Strategies
• 13.2. Company Share Analysis
• 13.3. Type Benchmarking

14. Company Profiles

• 14.1. 3M*
  • 14.1.1. Company Overview
  • 14.1.2. Product Portfolio and Description
  • 14.1.3. Key Highlights
  • 14.1.4. Financial Overview
• 14.2. BSN medical GmbH
• 14.3. DeRoyal Industries, Inc.
• 14.4. DJO, LLC
• 14.5. Orfit Industries n.v.
• 14.6. Ossur hf.
• 14.7. Prime Medical, Inc.
• 14.8. Spencer Italia S.r.l.
• 14.9. Stryker Corporation
• 14.10. Zimmer Holdings, Inc.

LIST NOT EXHAUSTIVE

15. Global Orthopedic Casts and Splints Market - DataM

• 15.1. Appendix
• 15.2. About Us and Services
• 15.3. Contact Us